Clinical Trial Update: A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients [NA]

View source ↗

Summary

This clinical trial evaluating Cytotoxic T Lymphocyte (CTL) therapy in HIV infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Cytotoxic T Lymphocyte (CTL) Therapy (cytotoxic T lymphocytes)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: TERMINATED